In 39 patients with acute meningococcal infections, the plasma concentrations of tumor necrosis factor-a (TNF) and its soluble receptors (sRs) TNFsR-p55 and TNFsR-p75 were measured from admission till recovery. At admission, patients with shock had significantly higher TNF, TNFsRp55, and TNFsR-p75 values than patients without shock. In addition, during the first 24 hours, patients with shock had higher TNFsR-p75 to TNFsR-p55 ratios, indicating that in shock the increase of TNFsR-p75 exceeds that of TNFsR-p55. TNF measured more than 12 hours after admission failed to differentiate between shock and nonshock because TNF concentrations normalized within 12 -24 hours. However, because concentrations of TNFsRs remained elevated for 5 -6 days, at that time plasma TNFsRs still differentiated between shock and nonshock. Plasma exchange or whole blood exchange (PEBE), performed in 20 patients with shock, accelerated the decrease of plasma TNFsRs. However, because of a rebound after each PEBE session, the overall half-lives of both TNFsRs were not affected by PEBE.
Tumor necrosis factor-a (TNF) is a pivotal mediator in the
To date, only limited data are available on the kinetic behavior of TNFsRs in relation to that of TNF in patients with pathogenesis of meningococcal infections [1, 2] . The biological activity of TNF is mediated via two TNF receptors on the a well-defined uniform infection and normal renal function. Therefore, we studied the kinetics of TNF, TNFsR-p55, and target cell, named TNF-RI (or TNFR-p55) and TNF-RII (or TNFR-p75) [3, 4] . Cells can modulate their sensitivity to TNF TNFsR-p75 from admission till recovery in patients with acute meningococcal infection, the prototype human disease of overby shedding the extracellular part of these receptors [5] . The resultant increased concentrations of TNF soluble receptors whelming endotoxin exposure. Because some of these patients were treated with plasma exchange or whole blood exchange (TNFsRs) further impede TNF bioactivity by preventing the binding of TNF to cell-associated receptors [6, 7] . However, (PEBE) [26] , the influence of this treatment on the kinetics of TNFsRs was also studied. the presence of TNFsR may also prolong the activity of TNF, as the complexed TNF can dissociate later in the course of the disease [8] . Because of these TNF-modulating effects and
Patients and Methods because of the interference of TNFsRs in some TNF laboratory
Patients. The study group comprised 39 patients with lifeassays [9, 10], insight into the kinetic behavior of TNFsRs may threatening meningococcal infections admitted from November be of help in understanding the biological role of TNF. 1990 to August 1995 to the intensive care unit of the University Experimental studies using bolus infusions of live bacteria Hospital Nijmegen (n Å 34) and the Eemland Hospital, Amers-[11], endotoxin [12, 13] , various cytokines [14 -17] , or antifoort (n Å 5). Patients were prospectively classified according CD3 antibodies [18] suggest different kinetics for TNF and to the absence (n Å 15) or presence (n Å 24) of shock. Shock TNFsR. Similarly, clinical observational studies showed persiswas defined by the occurrence of hypotension refractory to fluid tently elevated TNFsR levels in patients with sepsis of various resuscitation and requiring inotropic or vasoactive support; hyetiologies [19 -22] . From these studies it appeared that the potension was defined as a systolic blood pressure õ100 mm severity of the infectious insult determines the initial release Hg in adults, õ85 mm Hg in children younger than 14 years, of TNF and TNFsR. However, the kinetic behavior of TNFsR and õ75 mm Hg in children younger than 4 years [2]. appeared to be determined principally by the renal function
The patients without shock (nonshock patients/group) had a [23 -25] .
median Niklasson prognostic score [27] of 1 (range, 1 -2), and the patients with shock (shock patients/group) had a median score of 4 (range, 2 -6). Table 1 shows other prognostically [26] . In brief, in each session of plasma exchange,
The normal value of TNF, as measured in 143 healthy controls, performed in patients ú25 kg, 30 -40 mL of plasma per kg was 94 { 22 pg/mL (mean { SD). The assay detects both free was exchanged for fresh frozen plasma. In each session of and bound TNF. TNFsR-p55 and TNFsR-p75 were measured blood exchange, performed in children õ25 kg, 60 -80 mL of by an ELIBA (Hoffmann -La Roche, Basel, Switzerland). whole blood per kg was exchanged for citrate anticoagulated These assays were not influenced by the addition of human whole blood. recombinant TNF. Normal values for TNFsR-p55 were 1,470 PEBE was started as soon as possible after admission to the { 190 pg/mL, and for TNFsR-p75, 2,520 { 660 pg/mL. The intensive care unit and was repeated after 12, 24, and 48 hours median ratio of TNFsR-p75 to TNFsR-p55 in healthy controls if the condition of the patient was still critical. Each PEBE was 1.7 (range, 1.2 -2.2). Serum creatinine was measured by session took 1 -2 hours. The effect of PEBE on the endotoxin routine hospital laboratory procedures with a Hitachi 747 autopattern in six patients in the present study was reported prematic analyzer (Hitachi, Tokyo). The creatinine values are exviously [26] . The admission data regarding some proinflammapressed as a percentage of normal values adjusted to age and tory and anti-inflammatory cytokines of 30 patients have been gender [28] . published elsewhere [2] , and the pattern of IL-1b and its moduCalculations and statistics. The elimination of TNFsR-p55 lating agents in 34 of the patients was reported recently [29] .
and TNFsR-p75 was estimated with a log-linear model, deAll 15 nonshock patients survived; two had sensorineural scribed by the formula deafness. Five shock patients died: two died after 2.5 and 10 hours, without PEBE, and two died 18 and 28 hours post-
. . I-1) admission, after two PEBE sessions had been performed. One Å a 0 / k.t (i Å I) patient died after four PEBE sessions, when treatment was stopped 4 days after admission because of severely mutilating with gangrene, acidosis, and anuria.
Blood sampling. Blood sampling for assays for plasma C i (t) Å plasma concentration of the i-th patient at time t, TNF, TNFsR-p55, and TNFsR-p75 started a median of 3.0 C normal Å the upper normal reference range, expressed as mean hours (range 0.0 -11.1 hours) after hospital admission and / 2 SD (1,850 pg/mL for TNFsR-p55 and 3,840 stopped (in survivors) after a median of 156 hours (46 -210 pg/mL for TNFsR-p75), hours). Samples were drawn at frequent intervals during the I Å number of patients, first 2 days and once daily from day 3 to day 7. To quantitate a 0 , a i Å intercept parameters, and the effect of PEBE on the kinetics of TNFsR-p55 and TNFsRk Å slope parameter. p75, 15 of the 20 patients treated with PEBE (12 survivors and The parameters a 0 , a i , and k were calculated with multiple 3 nonsurvivors) had blood sampled just before and after each linear regression. The mean half-lives (i.e., ln 2/0k) were com-PEBE session. After sampling, blood was immediately centripared with Student's t-test. A Mann-Whitney U-test or Fisher's fuged twice and plasma or serum was stored at 020ЊC until exact test was used to compare nonshock and shock patients. P values of £.05 were considered significant. assay.
Results
At admission, the median plasma TNF concentration in patients without shock was 101 pg/mL (range, 60 -182 pg/mL). In patients with shock, the median TNF level was 323 pg/mL (range, 55 -1,800 pg/mL) (P Å .0003) for the complete group and 262 pg/mL (range, 55 -855 pg/mL) for survivors (P Å .002). Plasma TNF levels normalized within 1 day. TNF concentrations in nonshock and shock patients that were measured in later stages did not differ significantly ( figure 1, upper  panel) . This contrasted to the plasma concentrations of TNFsRp55 and TNFsR-p75, which were persistently and significantly more elevated in shock patients than in nonshock patients throughout the whole observation period ( figure 1, lower panels) .
Median TNFsR-p55 and TNFsR-p75 concentrations in nonshock patients at admission were 4,520 pg/mL (range, 2,330 -8,940 pg/mL) and 9,410 pg/mL (range, 5,060 -32,080 pg/mL), respectively. In surviving shock patients these values were 13,900 pg/mL (range, 2,630 -29,300 pg/mL) and 32,930 pg/mL (range, 12,220 -98,710 pg/mL) (both P õ .0001). The median ratio of TNFsR-p75 to TNFsR-p55 at admission for nonshock patients was 2.2 (range, 1.4 -4.0). This was slightly but significantly higher than for healthy controls (P Å .009). For shock patients, however, this ratio was much higher (median, 3.4; range, 1.8 -6.2) (P Å õ.0001). As seen in figure 2, the ratio normalized gradually during recovery.
The serum creatinine concentration in surviving shock patients at admission was higher than in nonshock patients (P Å .002) but normalized rapidly. On day 2 the median creatinine value in shock patients was 99% (range, 45% -141%), which did not differ significantly from that in nonshock patients.
The course of plasma TNFsR levels showed a biphasic pattern, with a rapid decline initially and a slower decrease during further recovery. In spite of the rapid normalization of renal function, 50% of the nonshock patients and 82% of the surviving shock patients had increased TNFsR values on day 4. The Å 25th to 75th percentiles, whiskers Å 5th to 95th percentiles. A However, detailed measurements just before and after PEBE Mann-Whitney U-test was used to compare nonshock and shock pasessions showed that PEBE influenced the TNFsR plasma pattients: *, P õ .05; **, P õ .01; ***, P õ .001. tern importantly, although this effect was only short-lasting ( figure 3 and table 2) . did nonshock patients. In addition, patients with shock had higher TNFsR-p75 to TNFsR-p55 ratios, indicating that their Discussion TNFsR-p75 levels were more elevated than their TNFsR-p55 levels. As plasma TNF normalized within 1 day, TNF concenThis study showed that, in patients with acute meningococcal infections, the plasma concentrations of TNF and its soluble trations measured more than 12 hours after admission failed to differentiate between nonshock and shock. receptors TNFsR-p55 and TNFsR-p75 follow different kinetics. At admission, patients with shock had significantly higher
In contrast, plasma TNFsRs normalized only slowly, over 5 -6 days, in spite of rapid restoration of the renal function plasma TNF, TNFsR-p75, and TNFsR-p55 concentrations than / 9c4a$$ap21 03-16-98 15:23:26 cida UC: CID Table 2 . Half-lives of tumor necrosis factor soluble receptor-p55 (TNFsR-p55) and TNFsR-p75 before, during, and after subsequent plasma exchange or whole blood exchange procedures. NOTE. PEBE Å plasma exchange or whole blood exchange. * No real figure; because of an increase in TNFsR over this period, the mean half-lives turned out to be ''negative.'' (within 2 days). Therefore, TNFsRs measured in the subacute stage still differentiated between nonshock and shock. PEBE influenced the plasma pattern of both TNFsRs by accelerating the decrease of plasma TNFsRs. However, as a rebound of receptor. This may be important for the toxic endotoxin effects such as shock, coagulation activation, and skin necrosis [31 -36] that are mainly mediated via the p55 receptor. Another explanation for the increased TNFsR-p75 to TNFsR-p55 ratio might be found in the excessive activation of complement, granulocytes, and endothelium during the initial stage of meningococcal shock [37, 38] .
Half-life (h)
Activated complement is believed to contribute to the shedding of TNFsR; in experimental sepsis, the shed TNFsRs appear in the circulation before the appearance of cytokines [39] . In addition, TNF-stimulated granulocytes shed selectively the p75 receptor [40] , and endothelial cells express more TNFRp75 than TNFR-p55 [41, 42] . Thus, the higher TNFsR-p75 to TNFsR-p55 ratio might be a reflection of these pathophysiological events in the early phase of meningococcal shock.
Support for these theories is found in our observation that in patients with less complement activation, intravascular neutrophil activation, and endothelial damage (i.e., patients with TNFsRs are therefore a better marker for the prognostic evaluanecrosis factor-a and soluble TNF receptor concentrations in severe tion of cytokine-mediated diseases [20, 21, 43] Persistently elevated TNFsR plasma concentrations may be a
